UiPath Inc (NYSE: PATH) reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday.
UiPath (PATH) experienced a decline in stock price after reporting its Q4 results, despite exceeding expectations and raising guidance. The company emphasized s
UiPath Inc (NYSE: PATH) opened in the red this morning after the firm's muted full-year outlook tempered its Q4 beat and announcement of a new $500 million share repurchase programme. To some, the sell-off may look like an overreaction, especially given that the software company posted its first-ever profit on a GAAP basis on March 12th.
UiPath Inc (NYSE:PATH) reported stronger-than-expected fourth-quarter results driven by healthy subscription growth and rising profitability. The automation software company posted revenue of $481 million, up 13.6% year-over-year and above analysts' estimates of $465 million.
UiPath (NYSE:PATH) declined approximately 6% in today's session, trading below $12 midday on Thursday.
UiPath, Inc. (PATH) Q4 2026 Earnings Call Transcript
UiPath's Q4 results showed 13.5% revenue growth, but this decelerated sequentially, and FY'27 guidance implies only ~10% top line growth. The new $500 million buyback is a plus for the company, but it may have less impact than bulls expect. It's still too early to say whether PATH will ultimately end up, on net, as benefitting from or being harmed by AI adoption.
While the top- and bottom-line numbers for UiPath (PATH) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UiPath (PATH) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.
The automation and AI platform said AI adoption from enterprise customers is moving from experimentation to scaled deployment.
PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.
UiPath, Inc. remains attractively valued after a 24% price drop, with macro and Claude-related fears appearing overblown given recent financial performance. PATH posted Q3 YoY revenue growth of ~16%, first-ever profitable Q3 EBIT, and robust ARR expansion, signaling resilience despite competitive AI threats. Management guides for continued ARR and sales growth in Q4, with a strong track record of beating both guidance and consensus expectations.